Cell Therapy News Volume 25.11 | Apr 1 2024

    0
    7








    2024-04-1 | CTN 25.11


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.09 – 1 April, 2024
    TOP STORY

    Regulatory T Cells Expressing CD19-Targeted Chimeric Antigen Receptor Restore Homeostasis in Systemic Lupus Erythematosus

    In a humanized mouse model of Systemic Lupus Erythematosus, a single infusion of Fox19CAR-Tregs restricts autoantibody generation, delayed lymphopenia, and restored the human immune system composition in lymphoid organs, without detectable toxicity.
    [Nature Communications]

    Full Article
    PUBLICATIONSRanked by the impact factor of the journal

    Induction of Immortal-Like and Functional CAR T Cells by Defined Factors

    Scientists demonstrated the induction of CAR T cells into an immortal-like and functional state, termed TIF. The induction of CARTIF cells depended on the repression of two factors, BCOR and ZC3H12A, and required antigen or CAR tonic signaling.
    [Journal Of Experimental Medicine]

    Abstract

    CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Two Patients with Multiple Sclerosis

    Researchers reported the first individual treatment with a fully human CD19 CAR-T cell therapy in two patients with progressive multiple sclerosis. CD19 CAR-T cell administration resulted in acceptable safety profiles for both patients.
    [Med]

    Full ArticleGraphical Abstract

    Biomaterial-Mediated Intracellular Control of Macrophages for Cell Therapy in Pro-Inflammatory and Pro-Fibrotic Conditions

    Poly(lactic-co-glycolic acid) microparticles encapsulating the anti-inflammatory and anti-fibrotic drug dexamethasone were administered to macrophages in vitro, with uptake rates controlled by different loading regimes.
    [Biomaterials]

    Full Article

    Need for Standardization of Cytokine Profiling in CAR T-Cell Therapy

    Scientists reviewed 21 clinical trials across 60 manuscripts that featured a Food and Drug Administration-approved CAR T-cell construct or one of its predecessors. They highlighted substantial variability and limited reporting of cytokine measurement platforms and panels used across CAR T-cell clinical trials.
    [Molecular Therapy]

    AbstractGraphical Abstract

    ATG or Post-Transplant Cyclophosphamide to Prevent GVHD in Matched Unrelated Stem Cell Transplantation?

    Investigators analyzed outcomes of rabbit anti-thymocyte globulin vs. post-transplantation Cyclophosphamide prophylaxis in adult patients with hematologic malignancies undergoing peripheral blood allogeneic stem cell transplantations from 10/10 antigen-matched unrelated donors.
    [Leukemia]

    Full Article

    Synergistic Dual Cell Therapy for Atherosclerosis Regression: ROS-Responsive Bio-Liposomes Co-Loaded with Geniposide and Emodin

    The authors present a ROS-responsive biomimetic nanocomplex co-loaded with Geniposide and Emodin in nanoliposome particles for targeted atherosclerosis therapy.
    [Journal Of Nanobiotechnology]

    Full Article

    UCNPs-Labeled Electrospun Scaffolds Used to Monitor In Vivo Degradation and Bone Tissue Regeneration

    Plycaprolactone/up-conversion nanoparticles/magnesium oxide composite scaffolds were prepared by electrospun based on the luminescence characteristics of up-conversion nanoparticles under near infrared excitation and the osteogenic ability of MgO.
    [Colloids And Surfaces B-Biointerfaces]

    Full Article

    Oncolytic Vaccinia Virus Immunotherapy Antagonizes Image-Guided Radiotherapy in Mouse Mammary Tumor Models

    Researchers tested whether combining image-guided ionizing radiation with an oncolytic vaccinia virus could yield a better therapeutic response than either treatment alone.
    [PLOS One]

    Full Article
    Access scientific and product support from STEMCELL Technologies
    REVIEWS

    The Opportunities and Challenges of the Disease-Modifying Immunotherapy for Type 1 Diabetes: A Systematic Review and Meta-Analysis

    Investigators performed a systematic review and meta-analysis to gain an overview of what a role immunotherapy plays in the treatment of type 1 diabetes.
    [Pharmacological Research]

    Full ArticleGraphical Abstract

    Harnessing the Potential of Self-Assembled Peptide Hydrogels for Neural Regeneration and Tissue Engineering

    The authors explore the capacity of neural cell regeneration and examine the critical aspects of self-assembled peptides in neuroregeneration, including their biochemical composition, topology, mechanical behavior, conductivity, and degradability.
    [Macromolecular Bioscience]

    Abstract
    INDUSTRY AND POLICY NEWS

    Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration with Labcorp

    Xcell Biosciences, Inc., an instrumentation company focused on cell and gene therapy applications, announced it has added new elements to its research collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services.
    [Xcell Biosciences, Inc. (BusinessWire)]

    Press Release

    Sweden’s NEOGAP Therapeutics Receives €500K Grant to Advance Personalized Cancer Immunotherapy Analysis

    NEOGAP Therapeutic has secured nearly €500K in funding from Eurostars for a collaboration project with the French biotech company Okomera. NEOGAP is developing pTTL, a personalized cell therapy utilizing modified proteins to activate the immune system against cancer cells.
    [ArticStartup]

    Press Release
    FEATURED EVENT

    Antibodies as Drugs: The Art in Antibody Engineering

    May 5 -8, 2024
    Beaver Run Resort, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Director – Cell Therapy Innovation

    Cellistic – Mont-Saint-Guibert, Belgium

    Laboratory Sciences Professional – Mesenchymal Stromal Cells

    University of Colorado – Aurora, Colorado, United States

    Laboratory Scientist – Cell Therapy Research

    University of Colorado – Aurora, Colorado, United States

    MSc/PhD Position – Cell Stress and Inflammation

    University of Manitoba – Winnipeg City, Manitoba, Canada

    Laboratory Scientist – Cell Therapy Research

    University of Colorado – Aurora, Colorado, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2